ClinicalTrials.gov
public full text
Public Domain
Study of NIB101 in Participants With Advanced Solid Tumors
NIB101-01 study is an open-label, non-randomized Phase 1 study in participants with GM2 positive advanced solid tumor, who failed to available standard of cares to evaluate the safety and tolerability of NIB101.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors#1150096
- A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma#887337
- Clinical Trial of BT02 in Patients With Advanced Solid Tumors#832384
- A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors#272344
- Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma#354269
Record · ID 854408
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive